Association between liver targeted antiviral therapy in colorectal cancer and survival benefits: An appraisal

被引：2
作者：
Wang, Qiang [1 ]
Yu, Chao-Ran [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Oncol, Shanghai Med Coll, 270 Dongan Rd, Shanghai 200025, Peoples R China
来源：
WORLD JOURNAL OF CLINICAL CASES | 2020年 / 8卷 / 11期
关键词：
Colorectal cancer; Liver metastasis; Antiviral therapy; Survival; Injury status; Biomarkers; HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; METASTASES; BLOCKADE;
D O I：
10.12998/wjcc.v8.i11.2111
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In colorectal cancer (CRC), liver metastasis remains a major contributor to the cause of cancer-related death. Putative biomarkers, therapeutic efficacy, and drug insensitivity still pose clinical challenges for metastatic CRC patients. Interestingly, previous studies indicated that tumor cells in CRC did not metastasize to the injured liver, which included hepatitis or cirrhotic liver. The benefits of antiviral therapy on hepatocellular carcinoma have also been identified. This review discusses the role of antiviral therapy on the liver. Antiviral therapy may reduce potential liver metastasis associated with CRC in several mechanistic aspects.
引用
收藏
页码：2111 / 2115
页数：6
相关论文
共 35 条
  • [1] Could hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?
    Altinoz, Meric A.
    Ozpinar, Aysel
    Ozpinar, Alp
    Hacker, Emily
    Elmaci, Ilhan
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46 (08) : 694 - 704
  • [2] Lower Incidence of Hepatic Metastases of Colorectal Cancer in Patients with Chronic Liver Diseases: Meta-analysis
    Augustin, Goran
    Bruketa, Tomislav
    Korolija, Dragan
    Milosevic, Milan
    [J]. HEPATO-GASTROENTEROLOGY, 2013, 60 (125) : 1164 - 1168
  • [3] Colorectal cancer
    Brenner, Hermann
    Kloor, Matthias
    Pox, Christian Peter
    [J]. LANCET, 2014, 383 (9927) : 1490 - 1502
  • [4] Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
    Chen, CJ
    Yang, HI
    Su, J
    Jen, CL
    You, SL
    Lu, SN
    Huang, GT
    Iloeje, UH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01): : 65 - 73
  • [5] Cancer Statistics in China, 2015
    Chen, Wanqing
    Zheng, Rongshou
    Baade, Peter D.
    Zhang, Siwei
    Zeng, Hongmei
    Bray, Freddie
    Jemal, Ahmedin
    Yu, Xue Qin
    He, Jie
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) : 115 - 132
  • [6] Clinical Relevance of Microsatellite Instability in Colorectal Cancer
    de la Chapelle, Albert
    Hampel, Heather
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3380 - 3387
  • [7] During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma
    Elias, D
    de Baere, T
    Roche, A
    Ducreux, M
    Leclere, J
    Lasser, P
    [J]. BRITISH JOURNAL OF SURGERY, 1999, 86 (06) : 784 - 788
  • [8] Hepatocellular carcinoma pathogenesis: from genes to environment
    Farazi, Paraskevi A.
    DePinho, Ronald A.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (09) : 674 - 687
  • [9] Molecularly-guided therapeutic options beyond tyrosine kinase inhibitors (TKIs) for gastrointestinal stromal tumors (GIST)
    Feldman, Rebecca
    Gatalica, Zoran
    Reddy, Sandeep K.
    Chawla, Sant P.
    Sankhala, Kamalesh Kumar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [10] Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis
    Goodwin, Tyler J.
    Huang, Leaf
    [J]. VACCINE, 2017, 35 (19) : 2550 - 2557
1234